Form 8-K Guardant Health, Inc. For: Nov 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Guardant Health (GH) PT Raised to $60 at Leerink Partners
November 7, 2024 5:56 AM ESTLeerink Partners analyst Puneet Souda raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: GH addressed two major questions weighing on the shares heading into the quarter: (1) slowdown in its... More
